Is Natraj Proteins overvalued or undervalued?

As of 10 September 2025, the valuation grade for Natraj Proteins has moved from expensive to very expensive, indicating a significant deterioration in its valuation outlook. The company is currently assessed as overvalued. Key ratios reveal a PE ratio of -15.62, an EV to EBITDA of 25.56, and a Price to Book Value of 0.48, all of which suggest that the company is not generating sufficient earnings relative to its valuation. In comparison to its peers, Natraj Proteins stands out unfavorably; for instance, Gokul Agro has a PE ratio of 18.97 and an EV to EBITDA of 9.43, while Guj. Ambuja Exp shows a PE of 20.89 and an EV to EBITDA of 11.29, both indicating a more favorable valuation. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -6.52%, contrasting sharply with the Sensex's gain of 4.21% over the same period, further reinforcing the notion that Natraj Proteins is overvalued.